As shown in Table 2 and Table 3, tumor patients with moderately and well differentiated grades had significantly higher positivity for PKM2 than those with a poorly differentiated stage (88.41% vs 43.75% in HCC, P < 0.01; 74.47% vs 40% in ICC, P < 0.01). Here, PKM is linked to hepatocellular carcinoma.